Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Radiat Oncol ; 6: 87, 2011 Jul 27.
Article in English | MEDLINE | ID: mdl-21794152

ABSTRACT

BACKGROUND: Our research compared whole pelvic (WP) and prostate-only (PO) 3-dimensional conformal radiotherapy (3DCRT) techniques in terms of the incidence and evolution of acute and late toxicity of the rectum and urinary bladder, and identified the PTV-parameters influencing these damages and changes in antitumor immune response. METHODS: We analyzed 197 prostate cancer patients undergoing 3DCRT for gastrointestinal (GI) and genitourinary (GU) toxicities, and conducted a pilot immunological study including flow cytometry and an NK cell cytotoxicity assay. Acute and late toxicities were recorded according to the RTOG and the LENT-SOMA scales, respectively. Univariate and multivariate analyses were conducted for factors associated with toxicity. RESULTS: In the WP group, an increase of acute rectal toxicity was observed. A higher incidence of late GI/GU toxicity appeared in the PO group. Only 18 patients (WP-7.76% and PO-11.11%) suffered severe late GI toxicity, and 26 patients (WP-11.21% and PO-16.05%) severe late GU toxicity. In the majority of acute toxicity suffering patients, the diminution of late GI/GU toxicity to grade 1 or to no toxicity after radiotherapy was observed. The 3DCRT technique itself, patient age, T stage of TNM classification, surgical intervention, and some dose-volume parameters emerged as important factors in the probability of developing acute and late GI/GU toxicity. The proportion and differentiation of NK cells positively correlated during 3DCRT and negatively so after its completion with dose-volumes of the rectum and urinary bladder. T and NKT cells were down-regulated throughout the whole period. We found a negative correlation between leukocyte numbers and bone marrow irradiated by 44-54 Gy and a positive one for NK cell proportion and doses of 5-25 Gy. The acute GU, late GU, and GI toxicities up-regulated the T cell (CTL) numbers and NK cytotoxicity. CONCLUSION: Our study demonstrates the association of acute and late damage of the urinary bladder and rectum, with clinical and treatment related factors. The 3DCRT itself does not induce the late GI or GU toxicity and rather reduces the risk of transition from acute to late toxicity. We have described for the first time the correlation between organs at risk, dose-volume parameters, and the immunological profile.


Subject(s)
Immune System/radiation effects , Prostatic Neoplasms/radiotherapy , Radiotherapy, Conformal/methods , Rectum/radiation effects , Aged , Aged, 80 and over , Bone Marrow Cells/cytology , Flow Cytometry/methods , Humans , Killer Cells, Natural/cytology , Male , Middle Aged , Multivariate Analysis , Pilot Projects , Radiotherapy Planning, Computer-Assisted/methods , Radiotherapy, Conformal/adverse effects , Risk , Urinary Bladder/radiation effects
2.
J Neuroimmunol ; 130(1-2): 55-65, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12225888

ABSTRACT

The involvement of catecholamine receptors (alpha-adrenergic, D2-dopamine (DA)) was investigated in restraint stress influenced immune responses with concomitant changes of G-protein signal transduction. Impairment of the spleen morphology, TH1/TH2 cytokine network and natural killer (NK) cell function was observed. In vivo administration of specific antagonists prior to restraint stress reversed the immunosuppression. These findings demonstrate that D2-type dopaminergic mechanism represents the dominant component in regulation of Galphas/Galphai(1,2)/Galphaq/11-protein signal transduction and contribute to cell responses at postreceptor level of both, central nervous and immune systems. G-protein-coupled receptors (GPCRs) can modulate cytokine production and may play a regulatory role in immune effector mechanisms.


Subject(s)
Immune System/immunology , Neurosecretory Systems/immunology , Receptors, Adrenergic, alpha/immunology , Receptors, Dopamine D2/immunology , Spleen/immunology , Stress, Physiological/immunology , Adrenergic alpha-Antagonists/pharmacology , Animals , B-Lymphocytes/cytology , B-Lymphocytes/immunology , Brain/drug effects , Brain/immunology , Brain/metabolism , Catecholamines/immunology , Dopamine Antagonists/pharmacology , Dopamine D2 Receptor Antagonists , GTP-Binding Proteins/immunology , Immune System/drug effects , Killer Cells, Natural/cytology , Killer Cells, Natural/immunology , Leukocytes, Mononuclear/cytology , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/immunology , Male , Mice , Mice, Inbred CBA , Neuroimmunomodulation/drug effects , Neuroimmunomodulation/immunology , Neurosecretory Systems/drug effects , Phenotype , Receptors, Adrenergic, alpha/drug effects , Spleen/cytology , Spleen/drug effects , Stress, Physiological/metabolism , Stress, Physiological/physiopathology , T-Lymphocytes/cytology , T-Lymphocytes/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...